Active	Status	Sponsor type	Region	Phase	Filter
2 Active 0 Inactive 2 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

1 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Huang, James
NCT01025089: Chemotherapy Plus Cetuximab Followed by Surgical Resection in Patients With Locally Advanced or Recurrent Thymoma or Thymic Carcinoma	Active, not recruiting	2	18	US	Cetuximab, Cisplatin, Doxorubicin & Cyclophosphamide	Memorial Sloan Kettering Cancer Center, Eli Lilly and Company, M.D. Anderson Cancer Center, City of Hope National Medical Center	Thymoma, Thymic Carcinoma, Clinical Masaoka Stage II to IVA	12/25	12/25
Stone, Hannah
No trials found